Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes

HER2-low and ultra-low breast cancer (BC) have been recently proposed as new subcategories of HER2 BC, supporting a re-consideration of immunohistochemical negative scores of 0, 1+ and the 2+/in situ hybridization (ISH) negative phenotype. In the present review, we outline the criteria needed to exa...

Descripción completa

Detalles Bibliográficos
Autores principales: Franchina, Mariausilia, Pizzimenti, Cristina, Fiorentino, Vincenzo, Martini, Maurizio, Ricciardi, Giuseppina Rosaria Rita, Silvestris, Nicola, Ieni, Antonio, Tuccari, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454084/
https://www.ncbi.nlm.nih.gov/pubmed/37628975
http://dx.doi.org/10.3390/ijms241612795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454084/
https://www.ncbi.nlm.nih.gov/pubmed/37628975
http://dx.doi.org/10.3390/ijms241612795

Ejemplares similares